التفاصيل البيبلوغرافية
| العنوان: |
Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network |
| المؤلفون: |
Ludwig H, Delforge M, Facon T, Einsele H, Gay F, Moreau P, Avet-Loiseau H, Boccadoro M, Hajek R, Mohty M, Cavo M, Dimopoulos MA, San-Miguel JF, Terpos E, Zweegman S, Garderet L, Mateos M-V, Cook G, Leleu X, Goldschmidt H, Jackson G, Kaiser M, Weisel K, van de Donk NWCJ, Waage A, Beksac M, Mellqvist UH, Engelhardt M, Caers J, Driessen C, Blade J, Sonneveld P |
| المصدر: |
Leukemia, 2 May 2018 |
| بيانات النشر: |
Nature Publishing Group |
| سنة النشر: |
2018 |
| المجموعة: |
Newcastle University Library ePrints Service |
| الوصف: |
© 2018 The Author(s) During the last few years, several new drugs have been introduced for treatment of patients with multiple myeloma, which have significantly improved the treatment outcome. All of these novel substances differ at least in part in their mode of action from similar drugs of the same drug class, or are representatives of new drug classes, and as such present with very specific side effect profiles. In this review, we summarize these adverse events, provide information on their prevention, and give practical guidance for monitoring of patients and for management of adverse events. |
| نوع الوثيقة: |
article in journal/newspaper |
| وصف الملف: |
application/pdf |
| اللغة: |
unknown |
| الإتاحة: |
https://eprint.ncl.ac.uk/fulltext.aspx?url=248350/3970BB12-B1A3-452B-BCC2-C10247A31B03.pdf&pub_id=248350Test |
| رقم الانضمام: |
edsbas.73F85FCE |
| قاعدة البيانات: |
BASE |
